87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Q&A: Managing menopause after cancer

Q&A: Managing menopause after cancer

byHuntsman Cancer InstituteCredit: Unsplash/CC0 Public DomainMenopause can bring a wave of physical and emotional changes—and for people with cancer, those changes can start earlier or feel more inten

Q&A: Managing menopause after cancer

byHuntsman Cancer InstituteCredit: Unsplash/CC0 Public DomainMenopause can bring a wave of physical and emotional changes—and for people with cancer, those changes can start earlier or feel more inten
RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc
Latin American research indicates a lower prevalence of a type of head and neck cancer

Latin American research indicates a lower prevalence of a type of head and neck cancer

by Maria Fernanda Ziegler,FAPESPCredit: Picas Joe from PexelsSquamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common c

Latin American research indicates a lower prevalence of a type of head and neck cancer

by Maria Fernanda Ziegler,FAPESPCredit: Picas Joe from PexelsSquamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common c
Living longer with tailored chemotherapy—despite incurable cancer

Living longer with tailored chemotherapy—despite incurable cancer

by Anne Sliper Midling,Norwegian University of Science and TechnologyAll rapidly growing cells in the body are affected by chemotherapy. Cancer cells are targeted, but so are, for example, hair cells

Living longer with tailored chemotherapy—despite incurable cancer

by Anne Sliper Midling,Norwegian University of Science and TechnologyAll rapidly growing cells in the body are affected by chemotherapy. Cancer cells are targeted, but so are, for example, hair cells
Medical patients face hidden time burdens: An overlooked cost of cancer care

Medical patients face hidden time burdens: An overlooked cost of cancer care

byUniversity of MinnesotaCredit: Pixabay/CC0 Public DomainTreatments for serious illnesses like cancer can be enormously time-consuming. Yet most research on cancer-related time burdens has relied on

Medical patients face hidden time burdens: An overlooked cost of cancer care

byUniversity of MinnesotaCredit: Pixabay/CC0 Public DomainTreatments for serious illnesses like cancer can be enormously time-consuming. Yet most research on cancer-related time burdens has relied on
Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from
Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

by Sbarro Health Research Organization (SHRO)Credit: Pixabay/CC0 Public DomainWhen patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and

Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

by Sbarro Health Research Organization (SHRO)Credit: Pixabay/CC0 Public DomainWhen patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and
Pancreatic cancer forms 'synapses,' scientists discover

Pancreatic cancer forms 'synapses,' scientists discover

by Paul Hellmich,Technical University MunichImmunofluorescence image of pancreatic cancer cells that invade nerves: nerve cells appear in green, tumor cells in red. Credit: Ekin Demir / TUMPancreatic

Pancreatic cancer forms 'synapses,' scientists discover

by Paul Hellmich,Technical University MunichImmunofluorescence image of pancreatic cancer cells that invade nerves: nerve cells appear in green, tumor cells in red. Credit: Ekin Demir / TUMPancreatic
PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

byUniversity of California - San DiegoCredit: Unsplash/CC0 Public DomainA new University of California San Diegostudyoffers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—t

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

byUniversity of California - San DiegoCredit: Unsplash/CC0 Public DomainA new University of California San Diegostudyoffers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—t
T cell therapies show long-term HPV gains

T cell therapies show long-term HPV gains

by Krista Didzbalis,Rutgers UniversityCredit: Pixabay/CC0 Public DomainResearchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer

T cell therapies show long-term HPV gains

by Krista Didzbalis,Rutgers UniversityCredit: Pixabay/CC0 Public DomainResearchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer
Genetic technique may enable precision treatment of pediatric brain tumors

Genetic technique may enable precision treatment of pediatric brain tumors

byUppsala UniversityS9RE-TK/GCV can significantly induce cell death of MB002 T-SOX9 in vitro. Credit:Neuro-Oncology Pediatrics(2025). DOI: 10.1093/neuped/wuaf005The malignant pediatric brain tumor med

Genetic technique may enable precision treatment of pediatric brain tumors

byUppsala UniversityS9RE-TK/GCV can significantly induce cell death of MB002 T-SOX9 in vitro. Credit:Neuro-Oncology Pediatrics(2025). DOI: 10.1093/neuped/wuaf005The malignant pediatric brain tumor med